Jane E. Hewitt
Nottingham, ENG NG72UH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.
Journal: Human molecular genetics
Published: June 10, 2015
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.
Journal: Neuromuscular disorders : NMD
Published: May 29, 2014
Formation of the embryonic organizer is restricted by the competitive influences of Fgf signaling and the SoxB1 transcription factors.
Journal: PloS one
Published: November 08, 2012
Evolution of DUX gene macrosatellites in placental mammals.
Journal: Chromosoma
Published: June 29, 2012
LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies.
Journal: Genome medicine
Published: March 31, 2012
Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis.
Journal: European journal of human genetics : EJHG
Published: March 02, 2012
Glycomarkers for muscular dystrophy.
Journal: Biochemical Society transactions
Published: January 27, 2011
Abnormal glycosylation of dystroglycan in human genetic disease.
Journal: Biochimica et biophysica acta
Published: March 31, 2009
Glycosylation defects in inherited muscle disease.
Journal: Cellular and molecular life sciences : CMLS
Published: April 08, 2003
Showing 1-9 of 9
Last Updated: 09/26/2026